viewBraveheart Investment Group

Braveheart Investment Group increases stake in company with technology to speed up plant growth

The additional £200,000 it is ploughing into Pharm 2 Farm will allow the business to open a new facility and expand its salesforce

Braveheart Investment Group -

Braveheart Investment Group PLC (LON:BRH) has increased its shareholding in a business called Pharm 2 Farm (P2F) to just under 52% from 33.33%.

The additional £200,000 it has ploughed in will allow P2F to open a new manufacturing facility in Nottingham and to expand its sales team.

P2F has developed a nano-particle technology that enables plants to grow more quickly. It can be used indoor and outdoor and alongside existing fertilisers on high nutrition crops such as chickpeas.

 "The interest shown in P2F products and technology since we acquired our original investment has significantly exceeded our expectations,” said Braveheart chief executive Trevor Brown.

“As a result, we have decided to step up our investment immediately, thereby providing P2F the funds necessary to accelerate its business plan."

Braveheart holds six strategic investments in its portfolio. These include biotechnology firm Kirkstall, UV light detection group Paraytec, propeller and rotating shaft monitoring group Gyrometric Systems, microscope imaging firm PhaseFocus and Sentinel Medical, a spin-out of Paraytec developing technology to detect cancer cells in urine.

Quick facts: Braveheart Investment Group

Price: 10.1 GBX

Market: AIM
Market Cap: £2.84 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Braveheart Investment Group named herein, including the promotion by the Company of Braveheart Investment Group in any Content on the Site, the...



Braveheart's Trevor Brown details investment in 'exciting' Pharm2Farm Limited

Proactive London's Andrew Scott speaks to Braveheart Investment Group PLC's (LON:BRH) and Pharm2Farm Limited's (P2F) Gareth Cave following Braveheart's investment in the business. P2F has developed a patented process to increase the bioavailability of trace minerals in plant feeds for...

on 15/7/19

2 min read